TAG-CO-VAC 每两年进行一次证据审查,以持续监测 SARS-CoV-2 的演变和疫苗诱导的免疫动力学(the kinetics of vaccine-derived immunity.)。 审查的证据 TAG-CO-VAC 审查的已发表和未发表的证据包括: (1) SARS-CoV-2 变异,包括早期和当前 SARS-CoV-2 变异株的遗传和抗原性特征,以及 SARS-CoV-2 演变对疫苗...
“The TAG-CO-VAC will also continue to reconvene every six months to evaluate the implications for COVID-19 vaccine antigen composition.” Reference 1. WHO. Statement on the Antigen Composition of COVID-19 Vaccines. Press Release. Dec. 23, 2024. https://www.who.int/news/item/23-12-2024...
WHO has established the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) to review and assess the public health implications of emerging SARS-CoV-2 Variants of Concern (VOC) on the performance of COVID-19 vaccines and to provide recommendations to WHO on COVID-19 vaccine...
WHO has established the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) to review and assess the public health implications of emerging SARS-CoV-2 Variants of Concern (VOC) on the performance of COVID-19 vaccines and to provide recommendations to WHO on COVID-19 vaccine...
The World Health Organization, with the support of the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), continues to review and assess the public health implications of emerging SARS-CoV-2 Variants of Concern (VOC) on the perfor...
The COVID-19 vaccine developed by China's Sinopharm has been approved by the World Health Organization (WHO) for "emergency use." This means its safety, efficacy and quality has been checked and it can be used by the international COVAX vaccine effort. WHO Director-General Tedros...
GENEVA, May 19 (Xinhua) -- The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinovac having been certified by WHO Emergency Use ...
“The Technical Advisory Group for Emergency Use Listing, convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19 and that the benefits of the vaccine far outweigh risks,“ the statement said....
"The Technical Advisory Group for Emergency Use Listing, convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19 and that the benefits of the vaccine far outweigh risks," the statement said. ...
"The Technical Advisory Group for Emergency Use Listing, convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19 and that the benefits of the vaccine far outweigh risks," the statement said. ...